Gene May Point to Risk for Anemia Drugs

Anemia drugs sold by Amgen and J&J have been under the safety spotlight for a while now, with some research suggesting the drugs may stimulate the growth of tumors in cancer patients. A study presented at this year’s American Society of Clinical Oncology conference points to a possible method for figuring out which patients are [...]